Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 21.0% in December

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decrease of 21.0% from the December 15th total of 8,100 shares. Based on an average daily trading volume, of 5,500 shares, the short-interest ratio is currently 1.2 days.

Lexaria Bioscience Stock Performance

Lexaria Bioscience stock traded down $0.10 during midday trading on Thursday, reaching $0.60. 22,501 shares of the stock were exchanged, compared to its average volume of 8,760. Lexaria Bioscience has a 52 week low of $0.45 and a 52 week high of $2.50. The company’s fifty day moving average is $0.74 and its 200-day moving average is $0.94.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.